Retatrutide trial results: 28.3% versus 20.8% by population
One peptide, two average weight-loss figures. The gap between 28.3% and 20.8% comes from who was enrolled in each trial, not from a different molecule.
A single number from a clinical trial is easy to repeat and hard to interpret. Two published figures for retatrutide show why. Both describe average weight loss with the same molecule, and they are about eight percentage points apart. The difference lies in the population each trial enrolled.
Two trials, two populations
The larger figure, 28.3%, came from a trial that excluded adults with type 2 diabetes. The smaller figure, 20.8%, came from a trial that enrolled adults with type 2 diabetes. The graphic that accompanied the original post labels these as TRIUMPH-1 and TRIUMPH-2 respectively.
The molecule is the same in both. What changes is the group in which the average was measured. A comparison of the two numbers is therefore a comparison of two populations as much as two datasets.
Why a headline figure needs its context
A headline result is usually the most favorable endpoint from the most favorable population. That does not make it wrong. It makes it specific. Quoting 28.3% without saying that the trial excluded type 2 diabetes drops the condition under which the number was produced. Quoting 20.8% without its population does the same in the other direction.
For a reader working from abstracts, three questions apply to any reported average:
- Who was enrolled, and who was excluded?
- What was the endpoint, and how was it calculated?
- Which trial does the figure come from, and is the other trial's figure being set beside it fairly?
What the evidence here does and does not show
The post establishes one narrow point: the same peptide produced different average results in two differently defined populations. It does not explain the gap. It does not give the size of either trial, the duration, the endpoint definitions or the spread around each average, and this article does not supply them. Without those details, the two figures should be read side by side only with their population labels attached.
That is a modest conclusion, but it is the one the data support. Same peptide, different population, different number.